Synlogic closes $29.4mm Series A; adds $5mm
Executive Summary
Synlogic Inc. (creating therapies based on its knowledge of the microbiome and synthetic biology) raised $29.4mm in its Series A financing led by Atlas Venture and New Enterprise Associates, which each add board representatives.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Technologies
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice